Mark Bertolini Sells 615,142 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 615,142 shares of Oscar Health stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $28.61, for a total transaction of $17,599,212.62. Following the transaction, the chief executive officer owned 9,581,734 shares in the company, valued at approximately $274,133,409.74. This trade represents a 6.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Down 1.4%

Shares of NYSE OSCR traded down $0.42 during trading on Monday, reaching $29.37. The company had a trading volume of 5,787,135 shares, compared to its average volume of 7,824,008. The company’s fifty day moving average price is $23.03 and its 200-day moving average price is $17.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market cap of $8.85 billion, a P/E ratio of -49.78, a PEG ratio of 2.08 and a beta of 2.37. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $30.66.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm’s revenue was up 52.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.92 earnings per share. As a group, research analysts expect that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Institutional Trading of Oscar Health

Hedge funds have recently modified their holdings of the stock. Empowered Funds LLC acquired a new position in shares of Oscar Health during the 1st quarter valued at $6,234,000. Bank of America Corp DE grew its holdings in Oscar Health by 205.1% in the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after purchasing an additional 1,922,732 shares during the period. Arkadios Wealth Advisors increased its stake in Oscar Health by 9.4% in the first quarter. Arkadios Wealth Advisors now owns 14,275 shares of the company’s stock valued at $164,000 after purchasing an additional 1,228 shares in the last quarter. Amundi bought a new stake in Oscar Health in the first quarter valued at $362,000. Finally, California State Teachers Retirement System raised its holdings in shares of Oscar Health by 23.3% during the first quarter. California State Teachers Retirement System now owns 235,443 shares of the company’s stock valued at $2,701,000 after purchasing an additional 44,443 shares during the period. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on OSCR shares. Wolfe Research assumed coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating for the company. Barclays upgraded Oscar Health from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $30.00 to $35.00 in a report on Wednesday, June 10th. Robert W. Baird lifted their price objective on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Finally, Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and upped their target price for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Oscar Health has a consensus rating of “Hold” and a consensus target price of $20.78.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.